11/17/2008 3:44:10 PM Scientists find a trigger to aggressive bowel cancer Scientists have shown how bowel cancer can become aggressive, according to research published in Nature Genetics. The researchers, based in the Cardiff School of Biosciences, Cardiff University and at Cancer Research UK’s Beatson Institute in Gl... more 11/17/2008 3:43:42 PM Cancer drug reverses diabetes in mice A drug developed to treat leukaemia has been found to also reverse diabetes in a mouse model of the disease. A new study by Cédric Louvet and colleagues reveals that imatinib (Gleevec) and another tyrosine kinase-inhibiting drug prevented or r... more 10/1/2008 4:15:49 PM Vitamin C surprise findings Vitamin C supplements have been found to reduce the benefit of a wide range of anticancer drugs when tested on mice and lab cells. In pre-clinical studies, vitamin C appears to substantially reduce the effectiveness of anticancer drugs, say resear... more 10/1/2008 4:14:41 PM 75 experts in international call for global cancer control An editorial in this month’s Annals of Oncology has called for the world’s growing cancer burden to be addressed. The authors highlight the World Health Organisation’s recent ‘Resolution on Cancer Control’ (WHA58.22) stating that its strong impetu... more 8/13/2008 3:59:49 PM Scientists use old enemy to K.O. cancer Metal ruthenium causes oxidants to attack cancer cells Chemists are pulling cancer onto a sucker punch by getting infected cells to drop their guard – according to research published today. They are using the metal ruthenium as a catalyst to ... more 8/5/2008 10:14:39 AM Depression hastens decline in cancer patients Depression causes patients with advanced cancer to die sooner than they should, say scientists at the University of Liverpool. In a six-month study patients who were found to be depressed had a 7% increased chance of dying and this percentage incr... more 7/9/2008 10:21:40 AM Risks identified for skin cancer recurrence The risk of cutaneous squamous-cell carcinoma (skin cancer) recurring or spreading around the body is increased when tumour thickness exceeds 6•0 mm or when desmoplastic growth occurs. Location at the ear or immune suppression also increase the risk ... more 6/12/2008 11:46:24 AM Tumour immunotherapy breakthrough Immune system found to induce tumour dormancy instead of kill: New line of attack Researchers from Tubingen University Department of Dermatology writing in Cancer Cell have uncovered an entirely new understanding of how the immune system may ... more 5/13/2008 12:29:36 PM People who participate in clinical research generally wish to know the research results A review of past studies examining whether people who participate in clinical research wish to know the results has found that most people do wish to be told, even if receiving the results might cause distress or anxiety. The review is published ... more 5/13/2008 12:02:50 PM Exercise benefit for certain women only Physically active women are 25 % less likely to get breast cancer, but certain groups are more likely to see these benefits than others, finds a review of research published online ahead of print in the British Journal of Sports Medicine. The ty... more 5/13/2008 11:56:08 AM Nationwide audit of screening programme reveals failure to be screened at recommended intervals is major risk factor for cervical cancer Failure to be screened for cervical cancer at the recommended time intervals is the major risk factor associated with developing the condition, according to the first nationwide audit of a cervical cancer screening program, which also revealed that... more 5/13/2008 10:24:24 AM Arsenic attacks leukaemia stem cells Unexpected discovery demonstrates key role for Promyelocytic Leukemia (PML) tumour suppressor gene. In both leukaemia and solid tumours, there exists a small subgroup of cancer stem cells, known as either cancer initiating cells (CICs) or leukaemi... more 5/9/2008 10:40:17 AM New cancer gene found Researchers at the Oklahoma University Cancer Institute, US, have identified a new gene that causes cancer. The ground-breaking research appears in cancer journal Oncogene. The gene and its protein, both called RBM3, are vital for cell division in... more 5/9/2008 10:32:15 AM Discovery of gene location that gives rise to neuroblastoma, an aggressive childhood cancer Using advanced gene-hunting technology, an international team of researchers has for the first time identified a chromosome region that is the source of genetic events that give rise to neuroblastoma, an often fatal childhood cancer. The invest... more 4/18/2008 10:49:52 AM Herceptin with neoadjuvant chemotherapy before surgery improves response rates for HER2 positive breast cancer A particularly aggressive form of breast cancer may be tackled better if treated with a combined anthracycline and taxane chemotherapy regimen before surgery, together with trastuzumab (herceptin) before and after surgery, according to results from t... more 4/18/2008 10:26:41 AM Acupuncture relieves hot flushes in tamoxifen patients Acupuncture provides effective relief from hot flushes in women who are being treated with the anti-oestrogen tamoxifen following surgery for breast cancer, according to new research presented at the 6th European Breast Cancer Conference. Mrs J... more 4/18/2008 10:26:13 AM 75 new age limit for mammograms - 3 yearly screening intervals best Breast cancer screening is appropriate and reduces deaths in women up to 75 years old according to new research in over 860,000 women aged 70-75 presented at the 6th European Breast Cancer Conference in Berlin. In another study of nearly 100,000 wo... more 4/18/2008 10:25:22 AM Standard chemo works better for BRCA1/2 cancer than for sporadic tumours Research to investigate the effects of chemotherapy on metastatic breast cancer in women with the BRCA1 or BRCA2 gene mutation has shown that standard chemotherapy works better in these patients than in women without the BRCA1/2 mutation. The s... more 4/18/2008 10:24:43 AM Lapatinib shrinks primary breast cancer tumours significantly in just six weeks A small scale trial of lapatinib, which targets cell surface receptors to regress tumours, has given remarkable results after just six weeks of use, it was announced at the 6th European Breast Cancer Conference in Berlin today. The research has... more 4/18/2008 10:24:07 AM Capecitabine and docetaxel combo ineffective in early breast cancer Adding capecitabine (xeloda) to docetaxel (taxotere) in patients with early breast cancer leads to more toxicities and does not improve the efficacy of treatment, a German scientist told the 6th European Breast Cancer Conference in Berlin today. ... more 4/18/2008 10:23:39 AM No link between aromatase inhibitors and cardiovascular problems New evidence has emerged that, contrary to some current fears, aromatase inhibitors (AIs) are not associated with an increased risk of heart problems in women who take them to prevent their breast cancer recurring. AIs, such as letrozole, anast... more 4/16/2008 2:26:06 PM Obese disadvantage in breast cancer treatment and diagnosis Obese women with breast cancer tend to have worse disease outcomes and more advanced disease at first diagnosis, it was revealed at the 6th European Breast Cancer Conference, Berlin. Dr. Elisabetta Rapiti and Dr. Evandro de Azambuja presented ... more 4/16/2008 12:57:46 PM Pre-surgery MRI scans recommended for all breast cancer patients The pre-op use of magnetic resonance imaging (MRI) in women diagnosed with breast cancer often leads to a better adapted surgical approach, a scientist told the 6th European Breast Cancer Conference today. Dr. David Martinez-Cecilia, a surgeon ... more 4/16/2008 12:57:16 PM Pregnancy should make no difference to treatment for breast cancer Pregnant breast cancer patients should be treated as closely as possible to existing guidelines for non-pregnant patients, a scientist told the 6th European Breast Cancer Conference today. Dr. Sibylle Loibl, Assistant Professor in Obstetrics and ... more 4/16/2008 10:56:00 AM Pre-emptive breast removal: Follow up not warranted New research presented today at the 6th European Breast Cancer Conference, Berlin, suggests that the risk of developing breast cancer after a prophylactic mastectomy is much lower than originally thought. Those found to carry the BRCA gene muta... more 4/14/2008 5:13:22 PM Alcohol consumption and risk of breast cancer in postmenopausal women One of the largest studies of its kind has found that alcohol is a substantial risk factor for development of the most common type of breast cancer - the 70 percent of tumours that are classified as positive for both the oestrogen and progesteron... more 4/14/2008 5:09:05 PM Hope for HER2 low-expressing breast cancer Response to preventive HER2/neu peptide (E75) vaccine based on HER2/neu status: A HER2 peptide E75 vaccine reduced mortality in patients with HER2-positive breast cancer by half, according to Texas researchers. In particular, patients with low... more 4/14/2008 3:18:15 PM Standard treatments should not be denied based on a patient's age A breast cancer patient's age alone should not determine whether or not she receives standard breast-conservation treatments, including a lumpectomy and radiation therapy; however, if additional health problems (comorbidities) are present, trea... more 4/14/2008 3:17:52 PM Arsenic's role in cancer cure discovered Scientists have discovered how arsenic works as an effective treatment for leukaemia - according to a report in Nature Cell Biology today. Patients with a certain kind of leukaemia (acute promyelocytic) can be successfully treated with arsenic, b... more 4/14/2008 3:17:17 PM Endoscopic removal of oesophageal surface tumours avoids major surgery The removal through endoscopy of tumours that affect only the superficial layers of the oesophagus can avoid complete removal of this part of the digestive tract. The technique, carried out at the University Hospital of Navarra for the last three y... more 4/11/2008 4:42:03 PM The European Society for Medical Oncology and the European CanCer Organisation join forces The European Society for Medical Oncology (ESMO) and the European CanCer Organisation (ECCO) have united to host a co-branded biennial multidisciplinary partnership meeting that will provide the best and most up to date scientific data for everyone... more 4/11/2008 4:41:20 PM Scientists ‘home in' on lung cancer genes that increase smokers' risk Scientists have pinpointed an area of the genome containing one or more genes that can put smokers at even more risk of developing lung cancer. Their findings are published online today in Nature Genetics. The international team of researcher... more 4/11/2008 4:40:53 PM Potential association of type 2 diabetes genes with prostate cancer Scientists have identified six new genes which play a role in the development of type 2 diabetes, and among the group is the second gene known to also play a role in prostate cancer. The new findings bring the total number of genes or gen... more 4/11/2008 4:40:25 PM New variants affect colorectal cancer risk Three new variants are associated with increased risk of colorectal cancer, according to two studies published online this week in Nature Genetics. The research also uncovers the first population-specific susceptibility allele for the disease. ... more 3/26/2008 10:53:30 AM MRI has a high false positive rate for women with a hereditary risk of breast cancer Magnetic resonance imaging (MRI) falsely detects breast cancer in five out of every six positive scans according to new research into the use of MRI for women with a high, inherited risk of developing the disease. The study, published today in Ann... more 3/13/2008 3:59:41 PM ‘Kingpin' gene controls aggressive breast tumours Geneticists have identified a gene that promotes aggressive breast cancer by altering the behaviour of more than 1,000 other genes within tumour cells. They also found that knocking out this ‘boss' gene causes the cancer cells to stop their runaway p... more 3/4/2008 3:52:07 PM High levels of oestrogen associated with breast cancer recurrence Women whose breast cancer came back after treatment had almost twice as much oestrogen in their blood than did women who remained cancer-free – despite treatment with anti-oestrogen drugs in a majority of the women –according to researchers in a st... more 2/27/2008 12:18:38 PM Novel pin point radiotherapy procedure proved success for breast cancer A large scale trial conducted at the European Institute of Oncology (IEO) in Milan has proved a novel radiotherapy procedure to be a great success both in terms of medical results and cost effectiveness. The study, published today in the peer-r... more 2/21/2008 3:33:57 PM European Parliament votes to postpone implementation of the EU Directive on electromagnetic fields The European CanCer Organisation (ECCO) has welcomed the European Parliament's overwhelming vote to postpone for four years the implementation of the EU Directive on electromagnetic fields. The EU Physical Agents (Electromagnetic Fields) Direc... more 2/21/2008 12:33:21 PM Specific genetic mutation found to increase risk of brain tumour Scientists have discovered a mutation in a DNA repair gene which may increase the risk of developing meningioma, a rare type of brain tumour, according to new research published in the latest edition of the Journal of the National Cancer Institute. ... more 2/18/2008 11:53:48 AM Insurance status and ethnic group predict stage of diagnosis for patients with various cancers US patients who are uninsured or have Medicaid insurance, and those from ethnic minorities, are significantly more likely to present with advanced cancer at diagnosis than privately insured patients, according to an article to be published in the... more 2/18/2008 11:52:01 AM Family doctors should be involved in long-term follow-up of childhood cancer survivors Family doctors should be involved in the long-term follow-up care of children who survive into adulthood after cancer, according to a Dutch study to be published in the March issue of The Lancet Oncology. 75% of children with cancer survive i... more 2/12/2008 11:03:30 AM Potential use of bacteria in cancer immunotherapy A strain of bacteria able to stimulate only a systemic immune response has been identified by a group at the European Institute of Oncology in Milan (IEO). The study, published in Immunity, may have significant relevance for the use of bacteria in ... more 2/5/2008 10:22:23 AM Breast cancer: Protein identified in resistance to tamoxifen An innovative research approach has identified a previously unsuspected protein as a key player in the resistance to particular forms of breast cancer therapy. The study, published in this month’s Cancer Cell significantly advances the understand... more 2/4/2008 4:31:18 PM EU approval of capecitabine for metastatic colorectal cancer Many more patients can now benefit from oral chemotherapy that significantly reduces treatment time. It was announced today (4.1.2008) that the European Commission has approved the oral chemotherapy capecitabine (Xeloda) for the treatment of m... more 2/4/2008 4:30:30 PM WORLD CANCER DAY - 4th February 2008 The International Agency for Research on Cancer (IARC) has announced its 2007 World Cancer Data Update and 2008 Statement of Cancer Challenges. The UN funded organisation collates data from around the globe and suggests trends in cancer and co... more 2/1/2008 4:17:40 PM Vaccine for prostate cancer developed Researchers at the University of Southern California have developed a prostate cancer vaccine that prevented the development of cancer in 90 percent of young mice genetically predestined to develop the disease. In the February issue of Cancer Resea... more 2/1/2008 4:08:42 PM Prostate cancer: Simple urine test An experimental biomarker test developed by researchers at the University of Michigan more accurately detects prostate cancer than any other screening method currently in use, according to a study published in the February 1 issue of Cancer Research,... more 1/25/2008 10:39:35 AM Oral contraception protects against ovarian cancer Use of oral contraceptives during a woman’s life-time gives substantial long-term protection against ovarian cancer, and the longer they are used, the greater the reduction in risk, according to an article in The Lancet. Use of oral contraceptives... more 1/22/2008 10:31:51 AM Body fat protein key in breast cancer spread Scientists have discovered how low levels of a protein hormone found in body fat, plays a crucial role in tumour growth and spread. Their findings are published in a paper in the British Journal of Cancer today (Tuesday). Postmenopausal women... more 1/22/2008 10:25:11 AM Ovarian cancer: Alcohol and smoking no effect, caffeine beneficial A new study has found that cigarette smoking and alcohol consumption do not have an effect on ovarian cancer risk, while caffeine intake may lower the risk, particularly in women not using hormones. The study is published in the March iss... more 1/22/2008 10:22:10 AM Sorafenib increases hypertension Sorafenib, a new anti-tumour drug used to treat patients with advanced renal-cell cancer (RCC) and hepatocellular cancer, significantly increases the risk of developing hypertension, according to an article to be published in the February issue of ... more 1/16/2008 11:24:49 AM Black women suffer breast cancer two decades earlier than white women Black British women in Hackney, London, are diagnosed with breast cancer 21 years younger than white British women, according to a Cancer Research UK study published online in the British Journal of Cancer. In the first UK study to look at the pat... more 1/16/2008 10:28:41 AM Pioneer of angiogenesis in cancer treatment dies Judah Folkman, M.D. (1933-2008) Judah Folkman, director of the vascular biology program at Children’s Hospital Boston and the Andrus professor of paediatric surgery and professor of cell biology at Harvard Medical School, died suddenly January 14,... more 1/15/2008 4:19:25 PM Dentists could check for breast cancer US scientists have found human saliva carries markers of breast cancer and have opened the door to the possibility that one day your doctor, or even your dentist, could do a simple saliva test for the disease. The discovery, published in the Janua... more 1/9/2008 10:16:08 AM Sun exposure may be better than not Sunbathing is known to have its pros and cons, but the debate over whether the benefits of sun exposure outweigh the risks from skin cancer remains constant. New research by scientists in Norway and the US, published in the Proceedings of the Nat... more 1/8/2008 10:32:17 AM Animal virus to kill cancer cells in humans UK scientists have used the immune system coupled with a virus found in horses and cattle, to hunt and purge cancer cells through the lymphatic system, a study reveals in Nature Medicine. Studying mice, the researchers found that the vesicular sto... more 1/2/2008 11:38:20 AM Key proteins discovered in tumour spread Scientists have unlocked the secrets of proteins involved in tumour cells creeping away from the original tumour and spreading around the body. Their findings are published in Molecular Cell. The study involves a protein called Tes which appears... more 12/18/2007 11:19:59 AM GlaxoSmithKline and OncoMed Pharmaceuticals form strategic alliance to develop cancer stem cell antibody therapeutics GlaxoSmithKline (GSK) and OncoMed Pharmaceuticals (OncoMed) have announced a worldwide strategic alliance to discover, develop and market novel antibody therapeutics to target cancer stem cells which are believed to play a key role in the establish... more 12/18/2007 11:08:22 AM GSK go ahead for lapatnib in Europe Announcement signals a new way to treat advanced or metastatic ErbB2 (HER2)-positive breast cancer GlaxoSmithKline (GSK) announced today that Tyverb® (lapatinib) has received a positive opinion recommending a conditional marketing authorisation... more 12/17/2007 4:09:24 PM Long-term treatment superiority of anastrozole over tamoxifen in early breast cancer “carries over” years after treatment has stopped New data from the landmark ATAC (Arimidex, Tamoxifen, Alone or in Combination*) trial have revealed that the benefits of managing hormone-sensitive early stage breast cancer (ESBC) with anastrozole, a 3rd generation aromatase inhibitor (AI), are ma... more 12/13/2007 5:36:22 PM Osteoporosis drug combats side effects of breast cancer drug A common osteoporosis drug can shield women against the loss of bone mineral density – a side effect of the drug anastrozole which is taken to prevent breast cancer in the IBIS-2 study – according to new data presented today at the San Antonio Brea... more 12/11/2007 12:46:51 PM New drug developed to outflank cancer resistance The drug has shown promising results against breast and prostate cancer cells and tumours that are resistant to conventional hormone-based treatments, according to research published in the British Journal of Cancer. Cancers such as breast ... more 12/10/2007 12:14:39 PM Key protein identified in paclitaxel success Scientists have discovered a protein which could improve the success rate of the tumour shrinking drug paclitaxel, in the treatment of ovarian cancer, a study reveals in Cancer Cell. The researchers found that the loss of a key protein called TG... more 12/10/2007 11:28:52 AM Stem cells made from skin cells; now no tumour risk The controversy over embryonic cell harvesting could soon be a thing of the past, after scientists reprogrammed human skin cells to mimic embryonic stem cells. The development promises an abundant source of cells for research into many diseases ... more 12/6/2007 4:21:51 PM New Asian cancer network Cancer researchers from around Asia are planning a landmark regional initiative to coordinate both data sharing and epidemiology. The network would gather data from cancer registries in countries from the Philippines to Turkey, an area th... more 12/4/2007 1:52:15 PM UK Pharma granted broad US patent for prostate cancer vaccine An immune system boosting anti cancer drug has been successfully patented in the US by a UK biotechnology company. ‘Onyvax-P’ consists of three prostate cancer cell lines, each representative of a different site or stage of prostate cancer. ... more 12/3/2007 11:29:33 AM UK cancer plan set out Prime Minister Gordon Brown and Health Secretary Alan Johnson today announced a 5 year plan to improve the UK’s tackling of cancer. Despite government spending on cancer services having tripled since the last plan in 2000, the UK has worse surv... more 11/30/2007 10:46:36 AM LigaSure not cost effective in breast cancer treatment A recent study at the European Institute of Oncology (IEO) has found that for removal of lymph nodes from the armpit, to treat breast cancer, the use of the new surgical device known as LigaSure, is not financially viable. Axillary lymph node di... more 11/14/2007 12:13:34 PM Gene signatures give best treatment for patients with breast cancer Gene signatures can be used to select the right treatment for patients with breast cancer, with the aim to give patients “tailored therapy” in the future, according to an Article to be published in the December issue of The Lancet Oncology. In the... more 11/14/2007 12:11:46 PM Cervical cancer risk reduces after stopping the pill Women taking the combined oral contraceptive pill are at an increased risk of cervical cancer but this risk starts falling soon after the pill is stopped, according to research published in the Lancet. The Cancer Research UK study shows that by te... more 11/14/2007 12:09:59 PM Potential for personalised light-activated cancer vaccines Cancer tissue taken directly from patients could be used to produce a light-triggered vaccine to target and treat their own tumours, according to a study published in the British Journal of Cancer. Photodynamic therapy (PDT) can be used to tr... more 11/7/2007 11:55:21 AM Cancer risks for overweight women Half of all cases of womb cancer and a type of oesophageal cancer in women are as a result of being overweight or obese, according to a new report published online in the British Medical Journal. This study provides the first reliable evidence... more 11/2/2007 4:23:52 PM Study shows survival traits for breast, lung, prostate and colorectal cancers are passed from parents to children Children whose parents had good survival after diagnosis of breast, lung, prostate, or colorectal cancers have better survival rates for cancers at the same site than children whose parents had died from these conditions. These are the conclusions of... more 10/22/2007 2:37:10 PM Cancer survival not influenced by patient’s emotional status A patient’s positive or negative emotional state has no direct or indirect effect on cancer survival or disease progression, according to a large scale new study. The research, to be published in the December issue of Cancer, found that emot... more 10/18/2007 2:45:30 PM Epstein Barr cancer vaccine: First results Researchers from the University of Birmingham and the Royal Marsden Hospital are using a vaccination for a common virus as a way of stimulating the body’s immune system to attack cancer cells. The preliminary results of this trial o... more 10/17/2007 3:29:31 PM GM cold virus kills cancer cells Researchers at the University of Birmingham have developed a method of using a genetically modified cold virus to target and kill tumour cells. Rather than delivering a drug, the virus acts as a method of delivering proteins that cause cancer cells t... more 10/17/2007 2:30:40 PM Conclusive report: Obesity does increase risk of liver cancer Liver cancer, the third most common cause of death from cancer worldwide, has been linked conclusively to obesity by researchers analysing 11 previous studies. The report, from the Karolinska Institute, Sweden, is the first meta-analys... more 10/11/2007 2:24:24 PM Foetal cells responsible for breast cancer risk reduction in mothers It is widely recognised that bearing children reduces the risk of breast cancer, now scientists believe they have identified the source of this benefit. Researchers at the University of Washington and Fred Hutchinson Cancer Research Centre have... more 10/11/2007 2:23:29 PM Stem cells key in cancer spread Bone marrow stem cells have been found to promote the spread of breast cancer to other areas, according to scientists working in a number of institutions in Massachusetts. The research, published this month in Nature, found that mesenchymal, or... more 10/5/2007 5:23:32 PM Lancet study demonstrates that thalidomide gives newly diagnosed multiple myeloma patients 18 month survival advantage Adding thalidomide to standard treatment improves the survival for patients suffering from a blood cancer by 18 months, according to research published in The Lancet today. In the study, 447 newly diagnosed patients with multiple myeloma, aged 65 ... more 10/4/2007 2:40:44 PM Smoking ban: Immediate effect on workers' health Staff in pubs, restaurants and bars across England have already benefited from a smokefree workplace, according to new research revealed at the National Cancer Research Institute Conference in Birmingham. Researchers from the Tobacco Control Col... more 10/4/2007 10:20:54 AM New combination of lung cancer targeted drugs works without standard chemotherapy Two new cancer drugs used in combination have been shown to be more effective than chemotherapy on its own, in a recent study carried out at a range of institutions in the US. The first, bevacizumab, is a drug targeted as an antibody t... more 10/4/2007 10:03:14 AM Promising new prostate cancer marker A new indicator of the nature of a prostate tumour could offer improved treatment through greater personalisation of therapy. A study from the Institute of Cancer Research (ICR) found that a marker known as 2+Edel, a fusion of two certain gene... more 10/2/2007 12:46:41 PM Cervical or testicular cancer increases likelihood of divorce Married couples are more likely to divorce if one spouse develops testicular cancer or cervical cancer, according to new research from Norway. The study, carried out by Mrs Astri Syse, a researcher at the Norwegian Cancer Registry in Oslo was ... more 10/2/2007 12:41:14 PM Booze is bad no matter what you drink The type of alcoholic beverage a woman drinks has no bearing on her risk of breast cancer, according to a comprehensive US study. Researchers from the Kaiser Permanente Medical Care Program in California found that it makes no difference wheth... more 10/2/2007 12:26:23 PM New kidney cancer drug shows promise An experimental drug has shown promise in patients with advanced kidney cancer whose tumours fail to respond to all other therapy. The study, presented by Dr Brian Rini from the Cleveland Clinic Taussig Cancer Institute, USA, found that the exp... more 10/2/2007 12:25:15 PM EU clinical trials directive hampers research Europe wide legislation is hampering clinical drug research according to research presented by Dr Markus Hartmann, from European Consulting and Contracting in Oncology, Germany. The ‘Clinical Trials Directive’ was put into force in May 2004 t... more 10/2/2007 12:09:26 PM New class of cancer treatment tackles melanoma A new drug has been found to attack cancer by an innovative, unprecedented method. ‘STA-4783’, developed by Synta Pharmaceuticals Corp., USA, has showed promise in treating advanced melanoma, slowing the progression of the disease and prolongin...